Adlai Nortye【ANL】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.22

買値

1.85

売値

2.99

出来高

3,325

2.18 日の範囲 2.31

0.00 52 週間の範囲 0.00

時価総額

81.919M

前日終値

2.2199

始値

2.18

時刻

2.22

最終取引時間

財務取引量

US$ 7,402

VWAP

2.2261

平均取引量 (3 か月)

発行済株式数

36,900,268

配当利回り

PER

-0.78

1 株当たり利益 (EPS)

-2.84

歳入

5.89M

純利益

-104.87M

Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The Company's pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005,... Adlai Nortye Ltd is a global clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The Company's pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. AN2025 is a pan-phosphoinositide 3-kinase (PI3K) inhibitor that is designed to act against solid tumors. AN2025 is undergoing Phase III, open-label clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (HNSCC) after anti-programmed death-1 (PD-1) or its ligand (PD-L1) treatment. AN0025 is a small molecule prostaglandin E receptor 4 (EP4) antagonist. AN4005 is an internally discovered oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include: AN8025, AN1025, and AN9025. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.adlainortye.com

本社

Grand Cayman, Cym

設立

Adlai Nortye Ltd is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ANL. The last closing price for Adlai Nortye was US$2.22. Over the last year, Adlai Nortye shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Adlai Nortye currently has 36,900,268 shares in issue. The market capitalisation of Adlai Nortye is US$81.91 million. Adlai Nortye has a price to earnings ratio (PE ratio) of -0.78.

Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage...

Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a global clinical-stage...

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 23, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage...

Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, May 22, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology...

Form S-8 - Securities to be offered to employees in employee benefit plans

Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, March 29, 2024 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage...

Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC

SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

ANL - Frequently Asked Questions (FAQ)

What is the current Adlai Nortye share price?

The current share price of Adlai Nortye is US$ 2.22

How many Adlai Nortye shares are in issue?

Adlai Nortye has 36,900,268 shares in issue

What is the market cap of Adlai Nortye?

The market capitalisation of Adlai Nortye is USD 81.91M

What is the 1 year trading range for Adlai Nortye share price?

Adlai Nortye has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Adlai Nortye?

The price to earnings ratio of Adlai Nortye is -0.78

What is the cash to sales ratio of Adlai Nortye?

The cash to sales ratio of Adlai Nortye is 13.91

What is the reporting currency for Adlai Nortye?

Adlai Nortye reports financial results in USD

What is the latest annual turnover for Adlai Nortye?

The latest annual turnover of Adlai Nortye is USD 5.89M

What is the latest annual profit for Adlai Nortye?

The latest annual profit of Adlai Nortye is USD -104.87M

What is the registered address of Adlai Nortye?

The registered address for Adlai Nortye is 4TH FLOOR, HARBOUR PLACE, 103 SOUTH CHURCH STREET, P.O. BOX 10240, GRAND CAYMAN, KY1-1002

What is the Adlai Nortye website address?

The website address for Adlai Nortye is www.adlainortye.com

Which industry sector does Adlai Nortye operate in?

Adlai Nortye operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BAOSBaosheng Media Group Holdings Ltd	US$ 7.10 (310.40%)	58.74M
HOURHour Loop Inc	US$ 4.40 (207.69%)	97.42M
GTIGraphjet Technology	US$ 0.61 (168.72%)	265.48M
CREVCarbon Revolution Public Ltd	US$ 9.16 (135.48%)	26.95M
AVGRAvinger Inc	US$ 1.45 (125.72%)	107.53M
SLGLSol Gel Technologies Ltd	US$ 0.9798 (-40.62%)	3.07M
DRCTDirect Digital Holdings Inc	US$ 3.71 (-32.55%)	23.82M
CHEKCheck Cap Ltd	US$ 1.55 (-31.11%)	3.49M
SYTASiyata Mobile Inc	US$ 0.5178 (-30.83%)	2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF	US$ 15.47 (-30.38%)	147.98k
SVMHSRIVARU Holding Ltd	US$ 0.0338 (20.71%)	280.27M
GTIGraphjet Technology	US$ 0.61 (168.72%)	265.48M
LITMSnow Lake Resources Ltd	US$ 0.5849 (52.84%)	181.22M
LCIDLucid Group Inc	US$ 3.20 (3.23%)	108.75M
RGTIRigetti Computing Inc	US$ 11.35 (3.56%)	108.38M